The macrophage activation marker, soluble CD163 is associated with hepatic inflammation and fibrosis in chronic viral hepatitis C and declines during effective direct-acting antiviral therapy

Autor:	Kazuaki Chayama, Holger Jon Møller, Jacob George, T.L. Laursen, C. Siggaard, Henning Grønbæk, Mark W. Douglas, K. Kazankov, T. Nakahara, Thomas Damgaard Sandahl, Peter Derek Christian Leutscher, Andrew T.L. Ong, Alex Lund Laursen, A. Hiramatsu
Jazyk:	angličtina
Rok vydání:	2017
Předmět:	Hepatology Gastroenterology & Hepatology business.industry Activation markers Antiviral therapy medicine.disease Hepatic inflammation Fibrosis Immunology medicine Macrophage Soluble cd163 Chronic viral hepatitis C business Direct acting
Zdroj:	Laursen, T L, Siggaard, C, Kazankov, K, Sandahl, T, Møller, H J, George, J, Ong, A, Douglas, M W, Laursen, A L, Leutscher, P, Hiramatsu, A, Nakahara, T, Chayama, K & Gronbaek, H 2017, ' The macrophage activation marker, soluble CD163 is associated with hepatic inflammation and fibrosis in chronic viral hepatitis C and declines during effective direct-acting antiviral therapy ', Journal of Hepatology, vol. 66, no. 1, SAT-282, pp. S742 . < http://www.sciencedirect.com/science/journal/01688278/66/1/supp/S?sdc=1 >
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9f92e3debc49f97ef59cd1c1bb73153 https://vbn.aau.dk/da/publications/74c35138-5887-471b-80b3-68b6f261d3a6 Zobrazit plný text záznamu